STEFFEN LANG
Novartis to save at least $1 bln by 2024 thanks to simplified structureThe company based in Basel appointed Marie-France Tschudin as president of innovative medicines international and chief commercial officer,...
Novartis agrees to make ingredients Roche's Actemra for COVID-19 patientsThe arrangement is the third transaction signed by Novartis following agreements with BioNTech and CureVac to make therapies for other firm...
- Load More